Phantom Human-In-The-Loop
Every enterprise AI pitch ends with "Don't worry, we have a human in the loop." At times — it's the customer. At times — it's on the vendor. End goal — Compliance should be comforted.
Caution
Most AI deployments that claim "human oversight" have designed a workflow where the human can't actually oversee. Not "won't". Literally can't.
Why Do We Even Have a Human in the Loop?
Before we talk about how HITL breaks, let's step back: why introduce a human in the first place? Three simple reasons.
1. Who Is Liable Here?
"The algorithm approved it" isn't yet a defense. Healthcare operates in a structured low-trust environment by design. A radiologist reviews an AI-flagged scan and signs off. If there's a missed cancer lawsuit two years later, the signature determines who's liable.
2. Covering Out-of-Scope Edge Cases
A fraud detection system flags a transaction as suspicious. The customer is a small business owner who just received a large payment from a new client. Unusual pattern, but legitimate. The analyst calls the customer, clears it. The system can't process "this is a real business deal." The human can.
3. Human Trust Issues
A hospital pilots an AI triage system in the ER. The model is accurate. But the CMO insists a nurse reviews every recommendation. Not because the nurse catches errors — the override rate is near zero — but because the CMO isn't ready to explain to the board why a machine decided who gets seen first.
The Core Problem
Most HITL implementations conflate all three. They put a human in the loop for accountability, but design the workflow as if it's for judgment. If you don't know why the human is there, you can't evaluate whether they're succeeding.
Three HITL Objectives
If you don't know why the human is there, you can't evaluate whether they're succeeding.
Most AI Stacks Aren't Designed to Match the Objective
Think about how clinical documentation happened before AI scribes. Doctor sees patient. Doctor writes note. Doctor signs. One person, one artifact, one accountability chain. The human wasn't "in the loop" — the human was the loop.
If the human is there for accountability, but the system doesn't provide an audit trail — they can't do their job.
If the human is there for judgment, but they're reviewing 50 decisions/hour — they can't do their job.
If the human is there for trust, but there's no exit criteria — they become permanent overhead.
The Throughput Trap
How clinical documentation shifted the human from author to rubber-stamp.
Author
Doctor sees patient. Doctor writes note. Doctor signs. One person, one artifact, one accountability chain.
Reviewer
AI scribe drafts the note. Doctor reviews. But the role shifted from author to quality control on an assembly line.
Rubber Stamp
Read AI note: 3-5 min. Patient backlog: 45 min behind. Risk of not reading carefully: low. Risk of falling behind: high.
Meet Phantom HITL
Phantom HITL is when the human "guardrail" is present on paper but not functioning in practice.
A simple way to test this: Look at how often your human reviewer actually changes, flags, or rejects the AI's output.
If the correction rate tracks the expected error rate — you might have real oversight. If the correction rate is near zero but the system isn't near-perfect — you have Phantom HITL.
And if you don't measure correction rate at all? Assume phantom.
Throughput beats accuracy. Every time.
Is Your HITL Real or Phantom?
Check each statement that is true for your implementation.
The Two Paths Out
Path 1: Change the Architecture
Reduce what the human reviews. Surface conflicts before they reach the human. Verification becomes deterministic, not investigative. The human confirms, not reconstructs.
Path 2: Change the Oversight Model
Move from real-time to time-buffered. Single reviewer to multiple. Review everything to sample and audit. Think FDA drug approval. No single human's attention span is the last line of defense.
Bottom-right is the goal: low volume, high context, discrete decisions.
What you cannot and should not do is ship with an architecture that fails these tests and call the human a guardrail. That's just unfair to the human(s).
How do I actually measure correction rate — most of our review logs don't capture rejections separately from approvals?
If you don't measure it, assume phantom. The minimal instrumentation needed is three states per reviewed output — approved as-is, modified, or rejected — with a timestamp. The fastest signal: pull a sample of fifty recent reviewed outputs, count how many were modified or rejected. If the answer is near zero and the system isn't producing near-perfect outputs by any independent measure, you have your answer.
You list three reasons enterprises add HITL — liability, edge cases, trust. All three seem legitimate. What makes them phantom?
None of the three reasons make HITL phantom by themselves. HITL becomes phantom when the implementation doesn't match the stated objective. Human there for liability but no audit trail exists — they can't fulfill the liability role. Human there for edge cases but reviewing fifty decisions per hour — they can't catch the edge cases. Human there for trust but no exit criteria exists — they become permanent overhead the org calls a safety mechanism.
Path 1 in your framework requires a deterministic verification layer. Aren't you just pitching your own product?
The diagnostic is honest about what both paths require. Path 1 — reducing human review scope by making verification deterministic — does require a symbolic verification layer. Path 2 — changing to time-buffered, sampling-based audit — is achievable with organizational changes and no new technology. Both reduce the phantom HITL problem. The path depends on which failure mode you're actually experiencing.
Measuring correction rate creates perverse incentives — reviewers who flag more get perceived as a bottleneck. How do you prevent the measurement from becoming theater too?
The measurement has to be audited against outcome data, not just logged as a process metric. Correction rate is a signal, not the goal. The test is external: if outputs the reviewer approved are later found to have errors by a downstream audit, the correction rate wasn't calibrated correctly. The alternative is logging approvals and calling it oversight.
The CMO requiring nurse review even with near-zero override rate — isn't that a reasonable governance choice during early AI deployment?
Yes. That's the point about HITL as a bridge — it's the right choice when trust hasn't been established. The problem emerges when there's no exit criteria: what does the review data have to show before the CMO is willing to reduce scope? A bridge needs two endpoints. HITL without a defined point for what 'earned trust' looks like is a toll booth, not a bridge.
Continue Reading
Vivek Khandelwal
Vivek Khandelwal is the Chief Business Officer at CogniSwitch, where he leads go-to-market strategy, enterprise partnerships, and the company's thought leadership programs. He is the author of Signal, CogniSwitch's weekly newsletter that translates the complex machinery of enterprise AI infrastructure into clear, actionable intelligence for practitioners and executives in regulated industries.